SBIR/STTR Reauthorization Act of 2025
- Bill Number
- S. 1573
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Commerce
- Status
- Introduced
- Latest Action
- 2025-05-01: Read twice and referred to the Committee on Small Business and Entrepreneurship.
- Last Updated
- 2026-01-21T04:40:20Z
AI-Generated Summary
SBIR/STTR Reauthorization Act of 2025 (S. 1573)
Purpose
This legislation reauthorizes and updates the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs under the Small Business Act. These programs provide federal funding to small businesses for research and development (R&D) to encourage innovation, technology commercialization, and economic growth. The Act extends program authority through fiscal year 2032 and beyond, increases funding levels, enhances participation for underrepresented groups, improves commercialization processes, and introduces safeguards and pilot initiatives.
Key Provisions
The Act is structured into six titles, amending Section 9 of the Small Business Act (15 U.S.C. 638) unless otherwise noted.
Title I: Reauthorization of Programs
- Extension of SBIR and STTR Authority: Removes expiration dates, making the programs permanent.
- Extension of FAST Program: Extends the Federal and State Technology (FAST) Partnership Program, which supports state-level assistance for small businesses in SBIR/STTR, from 2005 to September 30, 2030.
Title II: Enhancing Competition
- Increasing Agency Expenditures: Gradually raises the minimum percentage of extramural R&D budgets agencies must allocate to SBIR (from 3.2% in 2025 to 7% in 2032 and beyond) and STTR (from 0.45% in 2025 to 1% in 2032 and beyond).
- SBIR and STTR Fellowships: Allows agencies to fund fellowships and internships for undergraduates, graduates, and postdocs at small businesses with Phase II awards, with outreach to women and disadvantaged individuals; funded up to 3% of program budgets.
- Application Assistance: Expands assistance for underrepresented states and requires outreach to minority-serving and Hispanic-serving institutions (e.g., historically Black colleges, Tribal colleges).
- Technical and Business Assistance Improvements: Authorizes up to $6,500 for Phase I and $50,000 for Phase II awards for services like cybersecurity and staff training; includes I-Corps (Innovation Corps) training options.
- Website Improvements: Enhances public databases to report subcontracts with research institutions, including details on minority-serving institutions.
Title III: Commercialization Improvements
- Phase III Award Education: Mandates training for federal contracting officers on Phase III (commercialization phase) processes, including data rights and sole-source awards (direct contracts without competition).
- Report on Phase III Denials: Requires the Department of Defense to report denials of Phase III agreements to the Small Business Administration (SBA) within 30 days.
- Technology Commercialization Official: Each participating agency must designate an official to guide awardees on commercialization, coordinate markets, and report annually.
- Phase III Improvements: Directs procurement representatives to advocate for Phase III transitions; requires simplified procedures, model contracts, and standardized solicitations.
Title IV: Pilot Programs
- Assistance for Administrative Costs: Extends to 2030 and increases funding to 3.3% of budgets; requires 10% transfer from certain agencies (e.g., DoD, NIH) to SBA; supports outreach to underserved states.
- Direct to Phase II Authority: Expands to all agencies (previously limited), extends to 2030, with caps at 10% of SBIR funds (15% for NIH); requires reporting.
- Commercialization Readiness Program: Converts DoD pilot to a permanent program for civilian agencies, extended to 2030.
- Extensions of Other Pilots: Extends Phase 0 Proof of Concept (to 2030), commercialization assistance (to 2030), and due diligence for security risks (to 2030).
Title V: Oversight and Simplification Initiatives
- Annual Reports to Congress: Requires agencies to submit and publish detailed SBIR/STTR reports, including to small business committees.
- Comptroller General Report: Mandates a 3-year post-enactment report on program effectiveness in diversifying participants (e.g., new entrants, women-owned businesses) and commercialization.
- Extend Report on Award Timeliness: Extends to 11 years; adds data on review times for proposals.
- NIH Pilot Program: Establishes a pilot to speed up NIH SBIR/STTR awards (targeting 90 days from notice to funding) with flexible peer review; ends in 2030; requires evaluation report.
- Safeguards for Venture Capital-Owned Businesses: Codifies limits on SBIR participation for firms majority-owned by venture capital, hedge funds, private equity, or certain foreign entities (e.g., those tied to foreign adversaries or terrorist groups); applies to awards after enactment.
- Commercialization Impact Assessment: Annual SBA-coordinated assessment of high-award recipients' outcomes (e.g., revenues, investments, jobs); included in SBA's annual report.
Title VI: Technical Changes
- Inclusion of SBICs: Adds Small Business Investment Companies (SBICs, government-backed investors) to allowable ownership for SBIR/STTR participation.
- Phase III and Sole-Source Awards: Clarifies justifications for sole-source and other Phase III awards.
Significant Changes to Existing Law
- Funding Increases: Escalates mandatory SBIR/STTR allocations, potentially adding billions in funding over time (e.g., SBIR from ~$4 billion annually to higher levels).
- Permanency and Extensions: Removes SBIR expiration; extends STTR, FAST, and pilots to 2030–2032, preventing lapses.
- Equity Focus: New outreach mandates for underrepresented groups, institutions, and states; fellowships target women and disadvantaged individuals.
- Commercialization Enhancements: Introduces dedicated officials, training, simplified Phase III processes, and impact assessments; expands direct-to-Phase II beyond select agencies.
- Security Measures: Codifies foreign ownership restrictions with detailed definitions (e.g., "covered foreign entity" includes entities from countries of concern like China); extends risk assessments.
- Reporting and Oversight: Adds database transparency on subcontracts, annual impact reports, and GAO evaluation; includes SBICs in ownership rules.
Potential Impacts
- Government Agencies: Participating agencies (11 major ones like DoD, NIH, NASA) face higher funding obligations, increased administrative burdens (e.g., training, reporting, fund transfers to SBA), but gain tools for faster commercialization and risk mitigation. Could strain budgets but boost innovation alignment with agency needs.
- Citizens and Small Businesses: Expands opportunities for ~$4–5 billion in annual R&D funding to small firms (fewer than 500 employees), especially startups and underrepresented owners; fellowships create jobs and training. Improves access via assistance and pilots, potentially accelerating product development and economic growth.
- International Relations: Strengthens U.S. tech security by barring foreign-influenced entities from SBIR, reducing risks of technology transfer to adversaries; may deter foreign investment in U.S. small businesses but promote domestic innovation.
Main Stakeholders Affected
- Small Businesses: Primary beneficiaries, including startups, women-owned, minority-owned, and those in underserved states; gain funding, assistance, and commercialization support.
- Federal Agencies: DoD, NIH, Department of Energy, NASA, NSF, and others required to run SBIR/STTR; must allocate more funds and implement changes.
- SBA: Oversees programs, receives fund transfers, and coordinates reports/training.
- Research Institutions: Universities (especially minority-serving) and nonprofits benefit from subcontract reporting and outreach.
- Investors: Venture capital, hedge funds, private equity, and SBICs face new eligibility rules.
- Underrepresented Groups: Women, socially/economically disadvantaged individuals, and low-award states targeted for inclusion.
Notable Legal, Constitutional, or Political Implications
- Legal: Codifies and expands program rules, ensuring compliance with existing procurement laws (e.g., Federal Acquisition Regulation); introduces enforceable safeguards against foreign influence, potentially leading to disputes over ownership determinations. No direct challenges to peer review or award processes, but NIH pilot deems flexible reviews sufficient under health laws.
- Constitutional: Aligns with Congress's commerce clause authority to promote innovation and small business; promotes equal protection via equity measures without quotas.
- Political: Bipartisan focus on U.S. competitiveness (e.g., vs. China) and job creation; increases spending without new appropriations, relying on agency budgets—could spark debates on fiscal impacts. Enhances oversight via congressional reporting, aiding future policy tweaks; neutral on partisanship, emphasizing economic equity and national security.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Sen. Blumenthal, Richard [D-CT]
Recent Actions
- 2025-05-01: Read twice and referred to the Committee on Small Business and Entrepreneurship.
- 2025-05-01: Introduced in Senate
Bill Versions
- SBIR/STTR Reauthorization Act of 2025 — issued 2025-05-01 — PDF (53 pages)